Animal Blood Plasma Products & Derivatives
SKU
MRR-69324464D0E2
Region
Global
Publication Date
February 2024
Delivery
Immediate
2023
USD 752.59 million
2030
USD 1,114.33 million
2024
USD 795.11 million
CAGR
5.76%
Animal Blood Plasma Products & Derivatives Market by Derivatives Type (Fetal Bovine Serum, Fibrinogen, Immunoglobulin), Animal Type (Bovine, Ovine) - Global Forecast 2024-2030

[186 Pages Report] The Animal Blood Plasma Products & Derivatives Market size was estimated at USD 752.59 million in 2023 and expected to reach USD 795.11 million in 2024, at a CAGR 5.76% to reach USD 1,114.33 million by 2030.

Animal Blood Plasma Products & Derivatives Market
To learn more about this report, request a free sample copy
Animal blood plasma products and derivatives refer to components obtained from animal blood, primarily used for various therapeutic, nutraceutical, and pharmaceutical applications. Plasma derivatives include a range of bioactive components such as albumin, immunoglobulins, fibrinogen, and clotting factors, which play critical roles in physiological processes and are vital in the development of treatments for health conditions in both animals and humans. Several factors drive the demand for animal blood plasma components and derivatives. There is a growing need for animal-derived pharmaceuticals and the continual development of new biopharmaceuticals. Advances in bioscience and biotechnology also contribute to the utilization of these products. Moreover, the increasing prevalence of life-threatening diseases requiring plasma-derived proteins and the growing pet ownership with rising animal healthcare expenditure are pivotal drivers for expansion. The major challenges faced by animal blood plasma products and derivatives components include ethical concerns related to animal welfare, stringent regulations and compliances in plasma collection and processing, and the risks of transmission of zoonotic diseases. Additionally, the high cost associated with plasma fractionation and the availability of synthetic alternatives pose considerable challenges to market growth. Opportunities for animal blood plasma products and derivatives exist in the form of increasing investments in research and development for novel plasma-derived therapies. There is potential for expansion in emerging economies with improvement in their veterinary healthcare systems. The growing demand for high-quality feed additives for livestock performance is also a factor that may contribute to development. Furthermore, the enhancement of plasma collection and processing technologies promises to improve yield and reduce costs, thereby generating more opportunities.
Animal Blood Plasma Products & Derivatives Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Animal Blood Plasma Products & Derivatives Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Animal Blood Plasma Products & Derivatives Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Animal Blood Plasma Products & Derivatives Market, highlighting leading vendors and their innovative profiles. These include ACROBiosystems Inc., Alfa Laval Corporate AB, ANZCO Foods Limited, Auckland BioSciences Ltd., BioChemed Services, Biowest Company, Canvax Reagents S.L., Ebrator Biochemicals Inc., Kraeber & Co. GmbH, Lake Immunogenics, Inc., LAMPIRE Biological Laboratories, Inc., Meiji Holdings Co., Ltd., Merck KGaA, Moregate Biotech, Pel-Freez, LLC, Rockland Immunochemicals, Inc., Scripps Laboratories, Inc., and TCS Biosciences Ltd..

Market Segmentation & Coverage

This research report categorizes the Animal Blood Plasma Products & Derivatives Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Derivatives Type
    • Fetal Bovine Serum
    • Fibrinogen
    • Immunoglobulin
    • Serum Albumin
  • Animal Type
    • Bovine
    • Ovine

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Animal Blood Plasma Products & Derivatives Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Animal Blood Plasma Products & Derivatives Market?
  3. What are the technology trends and regulatory frameworks in the Animal Blood Plasma Products & Derivatives Market?
  4. What is the market share of the leading vendors in the Animal Blood Plasma Products & Derivatives Market?
  5. Which modes and strategic moves are suitable for entering the Animal Blood Plasma Products & Derivatives Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Animal Blood Plasma Products & Derivatives Market, by Derivatives Type
  7. Animal Blood Plasma Products & Derivatives Market, by Animal Type
  8. Americas Animal Blood Plasma Products & Derivatives Market
  9. Asia-Pacific Animal Blood Plasma Products & Derivatives Market
  10. Europe, Middle East & Africa Animal Blood Plasma Products & Derivatives Market
  11. Competitive Landscape
  12. Competitive Portfolio
Companies Mentioned
  • ACROBiosystems Inc.
  • Alfa Laval Corporate AB
  • ANZCO Foods Limited
  • Auckland BioSciences Ltd.
  • BioChemed Services
  • Biowest Company
  • Canvax Reagents S.L.
  • Ebrator Biochemicals Inc.
  • Kraeber & Co. GmbH
  • Lake Immunogenics, Inc.
  • LAMPIRE Biological Laboratories, Inc.
  • Meiji Holdings Co., Ltd.
  • Merck KGaA
  • Moregate Biotech
  • Pel-Freez, LLC
  • Rockland Immunochemicals, Inc.
  • Scripps Laboratories, Inc.
  • TCS Biosciences Ltd.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Animal Blood Plasma Products & Derivatives Market
The Global Animal Blood Plasma Products & Derivatives Market size was estimated at USD 752.59 million in 2023 and expected to reach USD 795.11 million in 2024.
The Global Animal Blood Plasma Products & Derivatives Market to grow USD 1,114.33 million by 2030, at a CAGR of 5.76%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.